Evidence map›Paper›PMID 33066172›Full record

ArticleCancers2020

Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor-Supporting Pathways.

Ivana Manini, Federica Caponnetto, Emiliano Dalla, Tamara Ius, Giuseppe Maria Della Pepa, Enrico Pegolo, Anna Bartolini, Giuseppe La Rocca, Grazia Menna, Carla Di Loreto and 4 more

Abstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Advancing glioblastoma therapy with surface-modified nanoparticles.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. The Chromatin-Oxygen Sensor GeneInternational journal of molecular sciences · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ivana ManiniInstitute of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Federica CaponnettoDepartment of Medicine, University of Udine, 33100 Udine, Italy.
Emiliano DallaDepartment of Medicine, University of Udine, 33100 Udine, Italy.ORCID 0000-0002-4687-6011
Tamara IusNeurosurgery Unit, Department of Neurosciences, University Hospital of Udine, 33100 Udine, Italy.
Giuseppe Maria Della PepaInstitute of Neurosurgery, Fondazione Policlinico Gemelli, Catholic University, 00168 Rome, Italy.ORCID 0000-0001-8698-3359
Enrico PegoloInstitute of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Anna BartoliniInstitute of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Giuseppe La RoccaInstitute of Neurosurgery, Fondazione Policlinico Gemelli, Catholic University, 00168 Rome, Italy.ORCID 0000-0003-1830-4849
Grazia MennaInstitute of Neurosurgery, Fondazione Policlinico Gemelli, Catholic University, 00168 Rome, Italy.ORCID 0000-0003-2594-4967
Carla Di LoretoInstitute of Pathology, University Hospital of Udine, 33100 Udine, Italy.
Alessandro OliviInstitute of Neurosurgery, Fondazione Policlinico Gemelli, Catholic University, 00168 Rome, Italy.
Miran SkrapNeurosurgery Unit, Department of Neurosciences, University Hospital of Udine, 33100 Udine, Italy.
Giovanni SabatinoInstitute of Neurosurgery, Fondazione Policlinico Gemelli, Catholic University, 00168 Rome, Italy.
Daniela CesselliInstitute of Pathology, University Hospital of Udine, 33100 Udine, Italy.ORCID 0000-0002-0562-7852

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glioblastoma microenvironment plays a substantial role in glioma biology. However, few studies have investigated its spatial heterogeneity. Exploiting 5-ALA Fluorescence Guided Surgery (FGS), we were able to distinguish between the tumor core (ALA+), infiltrating area (ALA-PALE) and healthy tissue (ALA-) of the glioblastoma, based on the level of accumulated fluorescence. The aim of this study was to investigate the properties of the microenvironments associated with these regions. For this purpose, we isolated glioma-associated stem cells (GASC), resident in the glioma microenvironment, from ALA+, ALA-PALE and ALA- samples and compared them in terms of growth kinetic, phenotype and for the expression of 84 genes associated with cancer inflammation and immunity. Differentially expressed genes were correlated with transcriptomic datasets from TCGA/GTEX. Our results show that GASC derived from the three distinct regions, despite a similar phenotype, were characterized by different transcriptomic profiles. Moreover, we identified a GASC-based genetic signature predictive of overall survival and disease-free survival. This signature, highly expressed in ALA+ GASC, was also well represented in ALA PALE GASC. 5-ALA FGS allowed to underline the heterogeneity of the glioma microenvironments. Deepening knowledge of these differences can contribute to develop new adjuvant therapies targeting the crosstalk between tumor and its supporting microenvironment.

Indexed as

5-aminolevulinc acidfluorescence guided surgeryglioblastoma microenvironmentglioma associated stem cellstumor supporting signature

Identifiers

PMID33066172
PMCPMC7601979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.